Co-Diagnostics, Inc. (CODX)

Co-Diagnostics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	11.44	2.94	14.92	22.97	88.61	42.98
Short-Term Investments	-	26.81	43.63	58.29	1.26	4.34
Cash & Short-Term Investments	11.44	29.75	58.55	81.26	89.86	47.31
Cash Growth	-69.61%	-49.19%	-27.95%	-9.57%	89.94%	5197.30%
Accounts Receivable	0.06	0.13	0.3	3.45	20.84	12.14
Other Receivables	0.92	-	0.03	1.95	0.08	-
Total Trade Receivables	0.98	0.13	0.33	5.4	20.91	12.14
Inventory	1.09	1.07	1.66	5.31	2	8
Other Current Assets	0.54	1.34	1.6	0.76	2.34	0.37
Total Current Assets	14.05	32.29	62.14	92.73	115.12	67.81
Net Property, Plant & Equipment	3.92	4.88	6	2.91	1.93	0.95
Other Intangible Assets	26.1	26.1	26.4	26.77	27.2	-
Goodwill	-	-	-	-	14.71	-
Long-Term Investments	0.66	0.73	0.77	0.67	1	1.93
Other Long-Term Assets	-	-	-	-	0.08	0.55
Total Assets	44.74	64	95.32	123.09	160.03	71.24
Accounts Payable	1.46	3.29	1.48	0.95	0.61	0.6
Accrued Expenses	1.2	2.56	2.17	0.93	3.86	2.97
Current Portion of Leases	0.74	0.92	0.84	0.3	-	-
Unearned Revenue	0.05	0.04	0.36	-	0.15	0.31
Other Current Liabilities	0.24	0.5	0.89	1.69	7.98	0.19
Total Current Liabilities	3.69	7.32	5.75	3.87	12.6	4.06
Long-Term Leases	0.73	1.24	2.15	0.05	-	-
Other Long-Term Liabilities	0.49	1.14	1.41	4.64	12.96	0.48
Total Long-Term Liabilities	1.22	2.37	3.56	4.69	12.96	0.48
Total Liabilities	4.91	9.69	9.31	8.57	25.56	4.54
Common Stock	0.05	0.04	0.04	0.03	0.03	0.03
Treasury Stock	-15.58	-15.58	-15.58	-14.21	-	-
Additional Paid-in Capital	109.45	102.47	96.81	88.47	80.27	49.16
Accumulated Other Comprehensive Income	0.09	0.42	0.15	0.29	-	-
Retained Earnings	-54.19	-33.04	4.6	39.93	54.17	17.51
Shareholders' Equity	39.83	54.31	86.01	114.52	134.48	66.7
Total Liabilities & Equity	44.74	64	95.32	123.09	160.03	71.24

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.